20 MYLAN 183
Pill imprint 20 MYLAN 183 has been identified as Propranolol hydrochloride 20 mg.
Propranolol is used in the treatment of high blood pressure; migraine prevention; performance anxiety; benign essential tremor; arrhythmia (and more), and belongs to the drug classes group II antiarrhythmics, non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy.
Propranolol 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Propranolol hydrochloride Images
- Imprint:
-
20
MYLAN 183 - Strength:
- 20 mg
- Color:
- Blue
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
pregelatinized starch
sodium lauryl sulfate
FD&C Blue No. 1 Aluminium Lake
- Drug Class:
- Group II antiarrhythmics
Non-cardioselective beta blockers - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0183
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0278 | UDL Laboratories Inc |
| 55289-0233 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Propranolol Hydrochloride resources
- Propranolol
- Propranolol (Wolters Kluwer)
- Propranolol Concentrate (Wolters Kluwer)
- Propranolol Solution (Wolters Kluwer)
- Propranolol Sustained-Release Bead Capsules (Wolters Kluwer)
- Propranolol Sustained-Release Capsules (Wolters Kluwer)
- Propranolol Tablets (Wolters Kluwer)
- propranolol (Cerner Multum)
- Propranolol HCl Intensol (Micromedex) - Includes Dosage Information
- propranolol (Micromedex) - Includes Dosage Information
- propranolol Intravenous (Micromedex) - Includes Dosage Information
- Propranolol Hydrochloride (AHFS DI)
- Propranolol (FDA)
- Propranolol Injection (FDA)
- Propranolol Oral Solution (FDA)
- Propranolol Tablets (FDA)
- Propranolol Hydrochloride (Wolters Kluwer)
Search Again
